AKR1B10 Serves as a Specific Biomarker for the Identification of Hepatocellular Ballooning Degeneration in MASH Patients
Liver International · 2026-07 · 46 (7)
DOI: 10.1111/liv.70712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, online erschienen am 03.06.2026. Verfasst von Jin-Zhong Li und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Disease, The First Affiliated Hospital of Jinan University, Guangzhou, China. Hauptthemen laut MEDLINE: Hepatocytes, Aldo-Keto Reductase Family 1 member B10, Fatty Liver. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Wang Baoen Liver Fibrosis Research Fund Project, The Young Scientists Fund of the National Natural Science Foundation of China, Medical Science Research Project of Hebei Province.
Abstract (Originalsprache)
Background
Hepatocellular ballooning degeneration distinguishes metabolic dysfunction‐associated steatohepatitis (MASH) from metabolic dysfunction‐associated steatotic liver (MASL), yet specific biomarkers are lacking.
Methods
The spatial transcriptomes of liver sections from human MASL and MASH patients and single‐cell data were used to examine hepatocyte ballooning. AKR1B10 and CK8/18 expression in 20 human liver samples were analysed by H&E staining and immunofluorescence. Serum AKR1B10 levels were quantified in 284 patients with various liver aetiologies to assess its differential expression across liver disease types and its diagnostic performance.
Results
Spatial and single‐cell transcriptomic analyses revealed significant AKR1B10 enrichment in the ballooned hepatocytes. The proportions of T cells and fibroblasts were significantly greater in ballooning regions than in steatotic regions. Immunostaining confirmed the localization of AKR1B10 in ballooning regions, along with the cytoplasm and cell membrane. This expression pattern was consistent with areas of cytokeratin CK8/18 loss; moreover, their combined application improved the ballooning diagnostic rate and accuracy. Serum AKR1B10 levels were markedly higher in patients with MASH than in individuals with other liver diseases ( p < 0.01) and correlated with ballooning severity ( R = 0.624). Ordinal logistic regression analysis indicated that the serum AKR1B10 level was strongly positively correlated with liver tissue ballooning severity (OR = 1.541 per unit, p = 0.003). The constructed model demonstrated significant discriminatory ability for identifying MASH patients with ballooning (AUC = 0.863).
Conclusions
AKR1B10 is a potential diagnostic and therapeutic biomarker for hepatocyte ballooning in MASH patients with strong spatial specificity and clinical value for noninvasive diagnosis, disease stratification, and treatment monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Disease, The First Affiliated Hospital of Jinan University, Guangzhou, China.
- Shijiazhuang Second Hospital, Hebei Provincial Key Laboratory of Basic Medicine for Diabetes, Shijiazhuang, China.
- Division of Pathology, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, China.
- School of Basic Medical Science, North China University of Science and Technology, Tangshan, China.
- Division of Liver Disease, The Fifth Hospital of Shijiazhuang, Hebei Medical University, Shijiazhuang, China.
- Center of Liver Diseases Division, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Ya-Juan Qi, Yi-Fan Han, Min-Ran Li
Förderung
- Wang Baoen Liver Fibrosis Research Fund Project
- The Young Scientists Fund of the National Natural Science Foundation of China
- Medical Science Research Project of Hebei Province
- Beijing Hospitals Authority Youth Program
- Key project of Traditional Chinese medicine Joint Fund of Hebei Province
Zitieren
APA
Li, J. Z., Zhang, L. L., Ye, L. H., Zou, W. W., Qi, Y. J., Wang, D. H., Cao, Y., Li, Q., Han, Y. F., Wang, Y., Dai, E. H., Lu, J. H., Chen, N., Zhang, H. C., Liu, Z. Q., Yang, L., Pan, Y., Zeng, D. Y., Xiao, M. X., & Li, M. R. (2026). AKR1B10 Serves as a Specific Biomarker for the Identification of Hepatocellular Ballooning Degeneration in MASH Patients. Liver International, 46(7). https://doi.org/10.1111/liv.70712
Vancouver
Li JZ, Zhang LL, Ye LH, Zou WW, Qi YJ, Wang DH, et al. AKR1B10 Serves as a Specific Biomarker for the Identification of Hepatocellular Ballooning Degeneration in MASH Patients. Liver International. 2026;46(7). doi:10.1111/liv.70712
BibTeX
@article{Li2026,
author = {Li, Jin-Zhong and Zhang, Li-Li and Ye, Li-Hong and Zou, Wei-Wei and Qi, Ya-Juan and Wang, De-Hua and Cao, Ying and Li, Qiang and Han, Yi-Fan and Wang, Yun and Dai, Er-Hei and Lu, Jian-Hua and Chen, Ning and Zhang, Hai-Cong and Liu, Zhi-Quan and Yang, Liu and Pan, Yun and Zeng, Dong-Yu and Xiao, Min-Xi and Li, Min-Ran},
title = {AKR1B10 Serves as a Specific Biomarker for the Identification of Hepatocellular Ballooning Degeneration in MASH Patients},
journal = {Liver International},
year = {2026},
volume = {46},
number = {7},
doi = {10.1111/liv.70712}
}
EUVIMED